Medpace raised its 2026 revenue outlook to $2.805-$2.885 billion and GAAP diluted EPS outlook to $17.25-$17.95 alongside its second-quarter results.
Korean translation
Medpace는 2분기 실적 발표와 함께 2026년 매출 전망을 28.05억~28.85억달러, GAAP 희석 EPS 전망을 17.25~17.95달러로 상향함.